Beyond Air (NASDAQ:XAIR) Shares Up 0.2% – Still a Buy?
by Scott Moore · The Cerbat GemBeyond Air, Inc. (NASDAQ:XAIR – Get Free Report)’s stock price shot up 0.2% on Monday . The stock traded as high as $0.5580 and last traded at $0.5450. 710,562 shares traded hands during trading, an increase of 79% from the average session volume of 397,597 shares. The stock had previously closed at $0.5440.
Analyst Ratings Changes
Several research firms recently weighed in on XAIR. Wall Street Zen upgraded shares of Beyond Air to a “sell” rating in a report on Saturday, March 7th. D. Boral Capital reiterated a “buy” rating and issued a $10.00 price objective on shares of Beyond Air in a report on Friday, March 27th. Finally, Rodman & Renshaw started coverage on shares of Beyond Air in a report on Tuesday, January 20th. They issued a “buy” rating on the stock. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $10.00.
Check Out Our Latest Stock Report on Beyond Air
Beyond Air Price Performance
The company has a debt-to-equity ratio of 2.65, a quick ratio of 4.77 and a current ratio of 5.12. The stock has a market cap of $5.68 million, a price-to-earnings ratio of -0.10 and a beta of 0.53. The business’s fifty day simple moving average is $0.80 and its 200 day simple moving average is $1.24.
Beyond Air (NASDAQ:XAIR – Get Free Report) last issued its earnings results on Friday, February 13th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.31). The company had revenue of $2.19 million during the quarter, compared to analyst estimates of $2.15 million. Beyond Air had a negative net margin of 447.75% and a negative return on equity of 268.82%.
Institutional Investors Weigh In On Beyond Air
A number of institutional investors have recently modified their holdings of XAIR. Alyeska Investment Group L.P. acquired a new stake in shares of Beyond Air in the 3rd quarter valued at about $1,753,000. Osaic Holdings Inc. raised its stake in shares of Beyond Air by 26.4% in the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock valued at $29,000 after purchasing an additional 34,000 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Beyond Air by 57.5% in the 4th quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after purchasing an additional 24,695 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Beyond Air in the 3rd quarter valued at about $48,000. Finally, Alpine Global Management LLC bought a new stake in shares of Beyond Air during the 3rd quarter valued at about $25,000. Institutional investors and hedge funds own 31.50% of the company’s stock.
Beyond Air Company Profile
Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.
The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.